amphetamine has been researched along with l 745870 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bristow, LJ; Collinson, N; Cook, GP; Curtis, N; Freedman, SB; Kulagowski, JJ; Leeson, PD; Patel, S; Ragan, CI; Ridgill, M; Saywell, KL; Tricklebank, MD | 1 |
Henry, BL; LaHoste, GJ; Marshall, JF | 1 |
Fan, X; Hess, EJ; Xu, M | 1 |
Connolly, NP; Gomez-Serrano, M | 1 |
4 other study(ies) available for amphetamine and l 745870
Article | Year |
---|---|
L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Male; Mice; Motor Activity; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Dopamine D4 | 1997 |
Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials.
Topics: Action Potentials; Amphetamine; Animals; Corpus Striatum; Dopamine Antagonists; Genes, fos; Indans; Indoles; Male; Piperidines; Proto-Oncogene Proteins c-fos; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Tetrodotoxin | 2000 |
D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD.
Topics: Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Benzopyrans; Corpus Striatum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extracellular Space; Indoles; Locomotion; Mice; Mice, Knockout; Mice, Mutant Strains; Piperidines; Pyridines; Pyrroles; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4 | 2010 |
D4 dopamine receptor-specific antagonist improves reversal learning impairment in amphetamine-treated male rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Attention; Behavior, Animal; Central Nervous System Stimulants; Cues; Dopamine Antagonists; Dose-Response Relationship, Drug; Executive Function; Learning Disabilities; Male; Molecular Targeted Therapy; Nootropic Agents; Pyridines; Pyrroles; Rats, Long-Evans; Receptors, Dopamine D4; Reversal Learning; Reward; Severity of Illness Index | 2014 |